Trial of New Alzheimer’s Drug Reports Disappointing Results June 16, 2022 crenezumab failed to prevent early symptoms or slow cognitive decline IFTTT NYT NYT > Business NYTimes The drug the latest setback in the long quest to find effective therapies for the disease. +